Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension

Kunal P. Pagar; Pradeep R. Vavia

doi:10.2478/v10007-012-0023-0

.blurhash-client-img { display: none !important; }

Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension

Acta Pharmaceutica

Volume 62 (2012): Issue 3 (September 2012)

By: Kunal P. Pagar and Pradeep R. Vavia

Open Access

|Nov 2012

1. B. Lemmer, Circadian rhythms and drug delivery,(1991) 63-74; DOI: 10.1016/0168-3659(91)90031-8.
Open DOI Search in Google Scholar
2. T. Bussemer, I. Otto and R. Bodmeier, Pulsatile drug delivery systems(2001) 433-458.
Open DOI Search in Google Scholar
3. T. Bussemer, A. Dashevsky and R. Bodmeier, A pulsatile drug delivery system based on rupturable coated hard gelatin capsules, J. Control. Release 93 (2003) 331-339; DOI: 10.1016/i.jconrel. 2003.08.012.
Search in Google Scholar
4. H. S. Michael and A. P. Nicholas, Chronobiology, drug delivery and chronotherapeutics(2007) 828-851; DOI: 10.1016/j.addr.2007.07.001.
Open DOI Search in Google Scholar
5. A. S. Mandal, N. Biswas, K. M. Karim, A. Guha, S. Chatterjee, M. Behera and K. Kuotsn, Drug delivery system based on chronobiology-A review(2010) 314-325; DOI: 10.1016/j.jconrel.2010.07.122.
Open DOI Search in Google Scholar
6. B. C. Youan, Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?(2004) 337-353; DOI: 10.1016/j.jconrel.2004.05.015.
Open DOI Search in Google Scholar
7The United States Pharmacopoeial Convention, Rockville 2006, pp. 884-885.
Search in Google Scholar
8. V. I. Teberekidis and M. P. Sigalas, Theoretical study of hydrogen bond interactions of felodipine with polyvinylpyrrolidone and polyethyleglycol(2007) 29-38; DOI: 10.1016/j.theochem.2006.09.016.
Open DOI Search in Google Scholar
9. M. Yasir, M. Asif, A. Kumar and A. Aggarval, Biopharmaceutical classification system: An account(2010) 1681-1690.
Search in Google Scholar
10. B. Abrahamsson, D. Johansson, A. Torstensson and K. Wingstrand, Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine(1994) 1093-1097.
Open DOI Search in Google Scholar
11. A. T. M. Serajuddin, Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs(1999) 1058-1066.
Search in Google Scholar
12. D. M. Bramhane, N. S. Saindane and P. R. Vavia, Inclusion complexation of weakly acidic NSAID with b-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component(2010) 453-460.
Search in Google Scholar
13. J. Mielcarek, A. Czernielewska and B. Czarczynska, Inclusion complexes of felodipine and amlodipine with methyl-b-cyclodextrin,(2006) 17-21.
Open DOI Search in Google Scholar
14. M. E. Brewster and T. Loftsson, Cyclodextrins as pharmaceutical solubilizers(2007) 645-666.
Open DOI Search in Google Scholar
15. E. Karavas, E. Georgarakis and D. Bikiaris, Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics,(2006) 115-126.
Open DOI Search in Google Scholar
16. L. M. Prisant, Hypertension and chronotherapy: Shifting the treatment paradigm(2001) 277S-279S.
Open DOI Search in Google Scholar
17. E. Karavas, E. Georgarakis and D. Bikiaris, Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer,.(2006) 189-197.
Open DOI Search in Google Scholar
18. T. Higuchi and K. A. Connors,, in, Wiley Interscience Publisher, New York 1965, pp. 117-212.
Search in Google Scholar
19. E. Karavas, E. Georgarakis, M. P. Sigalas, K. Avgoustakis and D. Bikiaris, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophobic carriers based on physical state of drug, particle size distribution and drug-polymer interactions,
Search in Google Scholar
(2007) 334-347; DOI: 10.1016/j.ejpb.2006.11.020.
Open DOI Search in Google Scholar
20. M. N. Reddy, T. Rehana, S. Ramakrishna, K. P. R. Chowdary and P. V. Diwan, b-cyclodextrincomplexes of celecoxib: Molecular-modeling, characterization, and dissolution studies,(2004) 1-9; DOI: 10.1208/ps060107.
Open DOI Search in Google Scholar
21. C. H. Marques, J. Hadgraft and I. Kellaway, Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC,.(1990) 259-266; DOI: 10.1016/0378-5173(90)90132-N.
Open DOI Search in Google Scholar
22. S. Suresh, H. N. Shivakumar and G. K. Kumar, Effect of b-cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets,(2006) 301-307; DOI: 10.4103/0250-474X.26657.
Open DOI Search in Google Scholar
23. F. F. Eugene and A. H. Timothy,inEdsL. Lachmann, H. A. Liberman and J. L. Kanig), 3rd ed., Varghese Publishing House, Mumbai 1987, p. 171.
Search in Google Scholar
24. K. Amareshwar and D. K. Rai, Spectroscopic studies of some antidiabetic drugs(2003) 1673-1680; DOI: 10.1016/S1386-1425(02)00405-5.
Open DOI Search in Google Scholar
25. I. Bratu, F. Veiga, C. Fernandes, A. Hernanz and J. M. Gavira, Infrared spectroscopic study of triacetyl-b-cyclodextrin and its inclusion complex with nicardipine,(2004) 459-467; DOI: 10.1155/2004/727869.
Open DOI Search in Google Scholar